Yi Kathy 4
4 · Theseus Pharmaceuticals, Inc. · Filed Jun 13, 2022
Insider Transaction Report
Form 4
Yi Kathy
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-10+30,000→ 30,000 totalExercise: $5.75Exp: 2032-06-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 10, 2023 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date.